Contact A Progressive Multifocal Leukoencephalopathy Lawyer
Raptiva, known generically as efalizumab, has been linked to the development of serious infections including progressive multifocal leukoencephalopathy (PML). Its manufacturer, Genentech, announced a voluntary recall of the Psoriasis medication April 8, 2009 in response to several reports of PML among Raptiva users.
If you or someone you love has been diagnosed with PML or another serious infection while taking Raptiva, you may be eligible to file a legal claim. For more information about your legal rights please fill out the contact form and an attorney for Raptiva patients will contact you shortly.
All information held in strictest confidence.
-- Privacy Protected --
ATTORNEY ADVERTISING -
Flood Law Group, LLP
1101 Pennsylvania Avenue
Suite 600
Washington, DC 20004
(888) 334-2084
Proud Members of the Better Business Bureau
